ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
Oligodendroglioma
Print
Other Resources UpToDate PubMed

Oligodendroglioma

Print Images (1)
Contributors: Andrea Wasilewski MD, Richard L. Barbano MD, PhD
Other Resources UpToDate PubMed

Synopsis

Oligodendrogliomas are tumors that arise from oligodendrocytes. They have diffuse infiltration and involve the white matter and cerebral cortex of the frontal and temporal lobes. Pathologically, they are characterized by round nuclei with perinuclear halos, with a classic "fried egg" appearance. Oligodendrogliomas are defined by molecular characteristics including isocitrate dehydrogenase (IDH 1/2) mutation and co-deletion of chromosomal arms of 1p and 19q. These tumors may be low grade (World Health Organization [WHO] grade II) or anaplastic (WHO grade III).

Most oligodendrogliomas occur in patients aged 20-50. Low-grade tumors are more common in younger patients. Seizures are a common presentation. Headaches and focal neurologic symptoms may occur but are uncommon clinical presentations. These are slow-growing tumors and may be clinically silent for years. Median survival ranges from 5-15 years. Survival is longer in younger patients, those with a complete resection, and those with lower-grade tumors.

Codes

ICD10CM:
C71.9 – Malignant neoplasm of brain, unspecified

SNOMEDCT:
443936004 – Oligodendroglioma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed: 12/04/2018
Last Updated: 12/04/2018
Copyright © 2019 VisualDx®. All rights reserved.
Oligodendroglioma
Print 1 Images
Oligodendroglioma : Seizures, Headache, Focal neurologic deficit
Copyright © 2019 VisualDx®. All rights reserved.